The viability of Giardia muris cysts was studied with the fluorogenic dyes fluorescein diacetate (FDA) and propidium iodide (PI). G. muris cysts were seen to fluoresce intensely green with FDA at an excitation wavelength of 450 to 490 nm. Cysts stained with PI fluoresced bright orange at an excitation wavelength of 450 to 490 nm and bright red at 545 to 546 nm. Examination of isolated G. muris cyst preparations stained with FDA-PI revealed that greater than 85% of the cysts stained green with FDA and less than 15% stained orange-red with PI. Using the mouse model for giardiasis, we inoculated FDA-or 
Methods used for determining the viability of Giardia cysts have included dye exclusion (2, 12) , excystation in vitro (2, 3, 12, 18) , and animal models for infectivity (19) . In dye exclusion methods, those cells that do not respire, glycolyse, or extend cellular processes when maintained in a tissue culture system have been shown to be stained with this technique (15) . Viable, living cells remain unstained. However, vital dyes have been shown to have a greater affinity for proteins in solution than for nonliving cells (17) and may be toxic at low concentrations (22) . In addition, vital dye results correlated poorly with other criteria when used to demonstrate Giardia cyst viability (2, 12) . Excystation would seem to be an indicator of the viability of Giardia cysts, since trophozoites must be released from the cysts to infect the host, but the broad definition of excystation used (2, 18) , which even includes aborted attempts at trophozoite emergence from the cysts, makes this method subjective and likely to overestimate true cyst viability. Models of animal infectivity require the use of cyst inocula with numbers extending up to several thousand. This technique may provide information about the viability of groups of cysts but reveals little pertaining to individual cysts. In addition, all of these methods are indirect tests in that the individual cysts tested are lost for further experimentation.
Since described in 1966 by Rotman and Papermaster (20) G. muris cysts were isolated from the feces of infected mice by the procedure of Roberts-Thomson et al. (19) . CF-1 non-Swiss mice (Harlan Sprague-Dawley) ( were given the appropriate inoculum. One animal per litter served as a control and was not inoculated.
Prior to inoculation, fecal exams had been performed daily on each animal for a period of 4 days to ensure that the animals did not have an endogenous infection. Also, one animal per litter was sacrificed to perform a microscopic examination of the mucosa for G. muris trophozoites.
Fecal examinations of individual animals were carried out on days 3, 5, 8, and 11 postinoculation with both zinc sulfate flotations and direct-smear fecal examinations. At the end of the experimental trial period, an animal from each group was sacrificed to microscopically check for the presence of trophozoites in the small intestine.
Cysts for the FDA incoculum were freshly isolated and stained with FDA-PI. The cyst inoculum number in one series of experiments was determined by the average number of FDA-positive cysts from four separate aliquots of the cyst suspension. In two separate experiments with FDApositive cysts obtained in this manner and counted with a hemacytometer, 1,000 cysts per animal and 50,000 cysts per animal were administered. In the other experimental series, aliquots of FDA-positive cysts were obtained with a fluorescence-activated cell sorter (FACS IV; Becton Dickinson and Co., Paramus, N.J.), and 1,000 cysts per animal were administered. All cysts were inoculated intragastrically via polyethylene tubing with a 1-ml syringe.
Cysts for the PI inoculum were obtained with an FACS IV and also through experimental induction by immersing cysts (500,000/ml) in a warm water bath at 80°C for 15 min. Microscopic examination of aliquots of both cyst suspensions showed all cysts to be PI positive. In one experimental group, 5,000 PI-positive cysts, obtained from the FACS IV, were administered to each animal. Another experimental group of mice was inoculated with 50,000 PI-positive cysts induced by heating. RESULTS Isolated cysts of G. muris were identified morphologically by light microscopy based on the following characteristics: shape, size, the presence of two to four nuclei usually in a polar position, and the appearance of linear structures representing flagellar axonemes ( Fig. la and c) . G. muris cysts incubated in the fluorogenic substrate FDA were seen to fluoresce intensely green (Fig. lb) . PI-stained cysts, when viewed with the excitor-barrier filter combination used for FDA (450 to 490 nm), were easily distinguishable from FDA-stained cysts as they fluoresced bright orange (Fig. ld) . Examination of PI-stained cysts at 545 to 546 nm revealed an intense red fluorescence. Investigation of routine G. muris cyst isolates (greater than 50) indicated that 85 to 90% of the cysts stained green with FDA, while less than 15% stained orange-red with PI. Occasionally, we observed G. muris cysts that did not metabolize FDA or intercalate PI and thus appeared black. Heating G. muris cysts for 15 min at 80°C converted all cysts to PI positivity ( Fig. lc and d) .
The viability of G. muris cysts was investigated by the administration of dye-exposed cysts to neonatal mice ( FDA was established by demonstrating that these cysts were capable of infectivity in 100% of the animals tested (n = 46) in a neonatal mouse system, whereas nonviable cysts stained with PI never produced an infection (n = 50). Using the FACS IV to sort cysts specifically stained with either FDA or PI or using cysts isolated with a sucrose density gradient, we demonstrated that only cysts stained with FDA were capable of producing an infection, as evidenced by fecal cyst shedding. In addition, PI-positive cysts, whether sorted in the FACS IV (cysts naturally stained with PI) or experimentally induced (by heat) to stain with PI, never produced an infection, even at doses that were 50-fold higher than the dose that produced an infection with FDA-positive cysts and 500 times the dose reported to produce an infection in mice (19) . Large doses of either FDA-or PI-stained cysts were administered to animals in this study. However, the use of dose-response experiments with FACS IV-isolated FDApositive cysts may permit a more precise determination of the minimum infective dose of G. muris. Nonetheless, the striking correlation between the uptake of FDA and animal infectivity together with the lack of it for PI-stained G. muris cysts clearly indicated that FDA cysts were viable, while PI cysts were not, as determined by animal infectivity.
Further support for the correlation of cyst viability with the incorporation of FDA lies in the fact that G. muris trophozoites were always detected at necropsy in the small intestines of mice infected with FDA-positive cysts but were never encountered in the small intestines of mice inoculated with PI-positive cysts. In addition to animal infectivity, the excystation of Giardia cysts has also been established as a criterion for cyst viability (2, 3, 16, 18) . We have observed (unpublished observation) FDA-positive cysts that underwent excystation and yielded free-swimming, motile trophozoites which were FDA positive. Similar results have never been observed for PI-stained cysts. A subpopulation of G. muris cysts that did not directly stain with FDA or PI was observed and appeared black. These nonstaining cysts were considered to be a subpopulation of the FDA-staining cysts since (i) black cysts were seen to convert to green fluorescence during microscopic examination, (ii) upon storage the proportion of black cysts decreased while the proportion of FDA-stained cysts increased and the proportion of PI-stained cysts remained the same, and (iii) inoculation of mice (n = 10) with nonstaining cysts isolated with the FACS IV resulted in infection (unpublished observations). Collectively, these data, determined by animal infectivity and excystation, both of which are established criteria for Giardia cyst viability (2, 3, 12, 18, 19) , have demonstrated the efficacy of the fluorogenic dyes FDA and PI in determining the viability of G. muris cysts.
Fluorogenic dyes have been accepted as a sensitive means for the determination of cell viability (20) . Fluorogenic dyes are molecules that are nonfluorescent and can serve as substrates in certain enzymatic reactions. Nonspecific intracellular esterases cleave the two acetate groups via their ester linkage in the nonpolar substrate FDA and have been shown to yield the polar molecular fluorescein, which fluoresces at an excitation wavelength of 450 to 490 nm (8) . It has been established that an intact lipid bilayer slows the leakage of the fluorochrome from within intact cells, while injured cells cannot retain or accumulate the fluorochrome (20) . In G. muris cysts fluorescein was observed to accumulate both within the trophozoite and within the space between trophozoite membrane and cyst wall (Fig. lb) suggests that in viable Giardia cysts both the bilipid membrane of the cell and the cyst wall may serve as barriers to the diffusion of fluorescein, whereas damaged or nonviable cysts may not accumulate fluorescein owing to the presence of disrupted membranes. Reports (7, 20) have implicated lipase, acylase, and proteinase in the hydrolysis of FDA, but the presence of these enzymes has not been investigated in Giardia trophozoites or cysts. Experimentation has shown FDA to be nontoxic to a wide variety of cell types, ranging from primitive eucaryotes to mammalian cells and tissues in culture (20) . The fluorogenic dye PI has not been known to traverse intact cell membranes; therefore, only cells with disrupted or broken membranes are counterstained by PI (9, 13) . The phenanthridinic fluorochrome PI has been shown to be specific for double-stranded nucleic acids and, upon intercalation, resulted in approximately a 25-fold increase in fluorescence emission at about 610 nm, with the maximum excitation peak at 530 nm (1) . PI has been shown to be nontoxic at up to 10 times the concentration used in this study (11) .
The use of fluorogenic dyes to investigate the viability of Giardia cysts should have several advantages over previously used methods, including dye exclusion (12), excystation (2, 3, 12, 18) , and animal infectivity (19) . First, the fluorogenic staining procedure is simple and inexpensive and requires only a few minutes to complete. However, the method must be carefully performed to obtain optimum staining. Particular attention should be paid to the concentration of dye used as a function of cell number and also the proper storage of stock or working solutions. A second advantage of using fluorogenic dyes is that direct results on the viability of cysts can be obtained on groups of cysts and individual cysts, which can then be subjected to further experimentation without compromising the sample. Third, the use of fluorogenic dyes should lend itself readily to the analysis of subpopulations of Giardia cysts by flow cytometry, since both FDA and PI have been successfully used for this purpose in a variety of cell types (4, 21) . Last, the effects of disinfectants and various environmental factors on the viability of Giardia cysts can be tested with fluorogenic dyes on the same population of cysts both before and after exposure to chemical or physical agents.
In conclusion, we have developed a method based on the use of fluorogenic dyes that is potentially useful for investigating the viability of Giardia cysts in vitro. This method should enable us to recover and thus characterize viable and nonviable Giardia cysts. Although it is assumed that Giardia cysts from a variety of species are similar, some differences have been noted in excystation (16) ; therefore, the application of fluorogenic dyes to cysts of different host origins or morphological types (5, 6, 14) may provide interesting information on cyst viability, morphology, and metabolism.
